Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ONCOLYTICS BIOTECH INC | 492,414 | reported | 12 Feb 2026 | tx 1+30,000 |
| Altimmune, Inc. | 13,498 | reported | 08 Jan 2026 | tx 16+263,600−67,202 |
| Provention Bio, Inc. | 0 | reported | 27 Apr 2023 | tx 13+238,681−238,681 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Feb 2026 | PURCHASE | ONCOLYTICS BIOTECH INC | 30,000 | 0.84 USD | |
| 08 Jan 2026 | PURCHASE | Altimmune, Inc. | 5,000 | 4.08 USD | first after silence |
| 25 Sept 2025 | GRANT_AWARD | Altimmune, Inc. | 48,800 | 0.00 USD | deriv |
| 26 Sept 2024 | GRANT_AWARD | Altimmune, Inc. | 34,900 | 0.00 USD | deriv |
| 28 Sept 2023 | GRANT_AWARD | Altimmune, Inc. | 26,100 | 0.00 USD | deriv |
| 27 Apr 2023 | TENDER | Provention Bio, Inc. | 7,500 | — | |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 24,000 | — | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 22,200 | — | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 23,000 | — | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 33,000 | — | deriv |
| 27 Apr 2023 | OTHER | Provention Bio, Inc. | 128,981 | — | deriv |
| 22 Dec 2022 | EXERCISE | Altimmune, Inc. | 20,000 | 2.60 USD | |
| 22 Dec 2022 | SALE | Altimmune, Inc. | 20,000 | 15.01 USD | |
| 22 Dec 2022 | EXERCISE | Altimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 29 Sept 2022 | GRANT_AWARD | Altimmune, Inc. | 23,500 | 0.00 USD | deriv |
| 17 May 2022 | GRANT_AWARD | Provention Bio, Inc. | 33,000 | 0.00 USD | deriv |
| 23 Sept 2021 | GRANT_AWARD | Altimmune, Inc. | 24,100 | 0.00 USD | deriv |
| 12 May 2021 | GRANT_AWARD | Provention Bio, Inc. | 23,000 | 0.00 USD | deriv |
| 12 Nov 2020 | SALE | Altimmune, Inc. | 10,352 | 9.90 USD | |
| 24 Sept 2020 | EXERCISE | Altimmune, Inc. | 16,850 | 0.00 USD | |
| 24 Sept 2020 | EXERCISE | Altimmune, Inc. | 16,850 | 0.00 USD | deriv |
| 24 Sept 2020 | GRANT_AWARD | Altimmune, Inc. | 25,500 | 0.00 USD | deriv |
| 15 Jul 2020 | GRANT_AWARD | Provention Bio, Inc. | 22,200 | 0.00 USD | deriv |
| 25 Jun 2020 | GRANT_AWARD | Altimmune, Inc. | 16,850 | 0.00 USD | deriv |
| 24 Jun 2019 | GRANT_AWARD | Provention Bio, Inc. | 24,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 Jan 2026.